[SCHEDULE 13G/A] Solventum Corporation SEC Filing
3M Company reported ownership of 25,569,190 shares of Solventum Corporation common stock, representing approximately 14.75% of the outstanding shares based on 173,387,798 shares outstanding as of July 31, 2025. The filing states that 3M granted Solventum a proxy under a Stockholder and Registration Rights Agreement dated March 31, 2024, so 3M does not exercise voting power over these shares and therefore reports 0 votes while retaining sole dispositive power to sell or direct disposition of the shares.
The Schedule 13G/A was signed on behalf of 3M Company by Kevin H. Rhodes, Executive Vice President, Chief Legal Affairs Officer & Secretary, dated August 18, 2025. The percentage is calculated from Solventum鈥檚 August 8, 2025 SEC filing reporting outstanding shares as of July 31, 2025.
3M Company dichiara di possedere 25.569.190 azioni ordinarie di Solventum Corporation, pari a circa il 14,75% delle azioni in circolazione, calcolato su 173.387.798 azioni in circolazione al 31 luglio 2025. Nel deposito si precisa che 3M ha concesso a Solventum una procura ai sensi di un Stockholder and Registration Rights Agreement datato 31 marzo 2024; di conseguenza 3M non esercita il potere di voto su tali azioni e dichiara pertanto di detenere 0 voti, pur mantenendo la piena facolt脿 dispositiva di vendere o disporre delle azioni.
Il Schedule 13G/A 猫 stato firmato per conto di 3M Company da Kevin H. Rhodes, Executive Vice President, Chief Legal Affairs Officer & Secretary, in data 18 agosto 2025. La percentuale 猫 stata calcolata sulla base del deposito SEC di Solventum dell'8 agosto 2025 che riporta le azioni in circolazione al 31 luglio 2025.
3M Company inform贸 la tenencia de 25.569.190 acciones ordinarias de Solventum Corporation, lo que representa aproximadamente el 14,75% de las acciones en circulaci贸n, con base en 173.387.798 acciones en circulaci贸n al 31 de julio de 2025. El expediente indica que 3M otorg贸 a Solventum un poder seg煤n un Stockholder and Registration Rights Agreement con fecha 31 de marzo de 2024; por ello 3M no ejerce poder de voto sobre estas acciones y reporta 0 votos, mientras conserva la facultad exclusiva de disposici贸n para vender o disponer de las acciones.
El Schedule 13G/A fue firmado en nombre de 3M Company por Kevin H. Rhodes, Executive Vice President, Chief Legal Affairs Officer & Secretary, con fecha 18 de agosto de 2025. El porcentaje se calcul贸 a partir de la presentaci贸n ante la SEC de Solventum del 8 de agosto de 2025 que informa las acciones en circulaci贸n al 31 de julio de 2025.
3M Company電� Solventum Corporation鞚� 氤错喌欤� 25,569,190欤茧ゼ 氤挫湢頃橁碃 鞛堧嫟瓿� 氤搓碃頄堨溂氅�, 鞚措姅 2025雲� 7鞗� 31鞚� 旮办 氚滍枆欤检嫕 齑濎垬 173,387,798欤茧ゼ 旮办鞙茧 鞎� 14.75%鞐� 頃措嫻頃╇媹雼�. 鞝滌稖靹滊鞐愲姅 3M鞚� 2024雲� 3鞗� 31鞚检瀽 Stockholder and Registration Rights Agreement鞐� 霐半澕 Solventum鞐� 鞙勳瀯鞛レ潉 攵�鞐枅旮� 霑岆鞐� 3M鞚� 頃措嫻 欤检嫕鞐� 雽�頃� 鞚橁舶甓岇潉 頄夓偓頃橃 鞎婌溂氅� 霐半澕靹� 0响�毳� 氤搓碃頃橁碃, 欤检嫕鞚� 毵る弰頃橁卑雮� 觳橂秳 歆�鞁滍暊 靾� 鞛堧姅 雼弲 觳橂秳甓�鞚� 鞙犾頃滊嫟瓿� 氇呾嫓霅橃柎 鞛堨姷雼堧嫟.
Schedule 13G/A電� Kevin H. Rhodes(Executive Vice President, Chief Legal Affairs Officer & Secretary)臧� 2025雲� 8鞗� 18鞚� 3M Company毳� 雽�鞁犿暣 靹滊獏頄堨姷雼堧嫟. 牍勳湪鞚� 2025雲� 7鞗� 31鞚� 旮办 氚滍枆欤检嫕鞚� 氤搓碃頃� Solventum鞚� 2025雲� 8鞗� 8鞚检瀽 SEC 鞝滌稖靹滊ゼ 旮办鞙茧 瓿勳偘霅橃棃鞀惦媹雼�.
3M Company a d茅clar茅 d茅tenir 25 569 190 actions ordinaires de Solventum Corporation, repr茅sentant environ 14,75 % des actions en circulation, sur la base de 173 387 798 actions en circulation au 31 juillet 2025. Le d茅p么t pr茅cise que 3M a accord茅 脿 Solventum une procuration en vertu d'un Stockholder and Registration Rights Agreement en date du 31 mars 2024 ; par cons茅quent, 3M n'exerce pas le pouvoir de vote sur ces actions et d茅clare 0 voix, tout en conservant le pouvoir exclusif de disposition pour vendre ou disposer des actions.
Le Schedule 13G/A a 茅t茅 sign茅 au nom de 3M Company par Kevin H. Rhodes, Executive Vice President, Chief Legal Affairs Officer & Secretary, en date du 18 ao没t 2025. Le pourcentage est calcul茅 脿 partir du d茅p么t aupr猫s de la SEC par Solventum du 8 ao没t 2025, qui rapporte les actions en circulation au 31 juillet 2025.
Die 3M Company meldete den Besitz von 25.569.190 Stammaktien der Solventum Corporation, was etwa 14,75% der ausstehenden Aktien entspricht, basierend auf 173.387.798 ausstehenden Aktien zum 31. Juli 2025. In der Einreichung hei脽t es, dass 3M Solventum gem盲脽 einer Stockholder and Registration Rights Agreement vom 31. M盲rz 2024 eine Vollmacht erteilt hat, weshalb 3M 眉ber diese Aktien keine Stimmrechte aus眉bt und daher 0 Stimmen angibt, w盲hrend sie die ausschlie脽liche Verf眉gungsbefugnis zum Verkauf oder zur anderweitigen Verf眉gung 眉ber die Aktien beh盲lt.
Das Schedule 13G/A wurde im Namen der 3M Company von Kevin H. Rhodes, Executive Vice President, Chief Legal Affairs Officer & Secretary, am 18. August 2025 unterzeichnet. Der Prozentsatz wurde auf Grundlage der SEC-Einreichung von Solventum vom 8. August 2025 berechnet, die die ausstehenden Aktien zum 31. Juli 2025 angibt.
- Material economic stake: 3M beneficially owns 25,569,190 shares (~14.75%), a meaningful ownership position.
- Sole dispositive power: 3M retains the ability to sell or direct disposition of the full share block.
- Clear disclosure: Filing cites the Stockholder and Registration Rights Agreement and quantifies shares and percentage based on outstanding shares.
- No voting power: 3M reports 0 shares with sole or shared voting power due to the proxy arrangement.
- Potential governance limitation: Despite economic exposure, 3M cannot unilaterally influence corporate votes through this stake.
Insights
TL;DR: 3M retains a sizable economic stake in Solventum (14.75%) but has no voting power due to a proxy arrangement.
3M鈥檚 25.57 million-share position is material relative to the 173.39 million shares outstanding, representing nearly 15% ownership. That level of ownership is large enough to influence valuation perceptions and secondary-market liquidity for Solventum shares. However, because 3M has granted a proxy to vote in proportion to other stockholders, its economic exposure is not matched by independent voting control, reducing its direct governance influence. For investors, the key takeaway is a meaningful economic stake without unilateral voting authority.
TL;DR: The proxy-based voting arrangement limits 3M鈥檚 governance control despite a substantial ownership stake.
The Stockholder and Registration Rights Agreement dated March 31, 2024, and the proxy described in this filing indicate a deliberate separation of economic ownership from voting control. This arrangement can reassure Solventum鈥檚 independent governance by preventing a large shareholder from exercising block voting while still allowing 3M to monetize or transfer its economic interest. Materially, the filing clarifies that all voting power is exercised proportionally, which reduces the likelihood of a control contest arising solely from 3M鈥檚 stake.
3M Company dichiara di possedere 25.569.190 azioni ordinarie di Solventum Corporation, pari a circa il 14,75% delle azioni in circolazione, calcolato su 173.387.798 azioni in circolazione al 31 luglio 2025. Nel deposito si precisa che 3M ha concesso a Solventum una procura ai sensi di un Stockholder and Registration Rights Agreement datato 31 marzo 2024; di conseguenza 3M non esercita il potere di voto su tali azioni e dichiara pertanto di detenere 0 voti, pur mantenendo la piena facolt脿 dispositiva di vendere o disporre delle azioni.
Il Schedule 13G/A 猫 stato firmato per conto di 3M Company da Kevin H. Rhodes, Executive Vice President, Chief Legal Affairs Officer & Secretary, in data 18 agosto 2025. La percentuale 猫 stata calcolata sulla base del deposito SEC di Solventum dell'8 agosto 2025 che riporta le azioni in circolazione al 31 luglio 2025.
3M Company inform贸 la tenencia de 25.569.190 acciones ordinarias de Solventum Corporation, lo que representa aproximadamente el 14,75% de las acciones en circulaci贸n, con base en 173.387.798 acciones en circulaci贸n al 31 de julio de 2025. El expediente indica que 3M otorg贸 a Solventum un poder seg煤n un Stockholder and Registration Rights Agreement con fecha 31 de marzo de 2024; por ello 3M no ejerce poder de voto sobre estas acciones y reporta 0 votos, mientras conserva la facultad exclusiva de disposici贸n para vender o disponer de las acciones.
El Schedule 13G/A fue firmado en nombre de 3M Company por Kevin H. Rhodes, Executive Vice President, Chief Legal Affairs Officer & Secretary, con fecha 18 de agosto de 2025. El porcentaje se calcul贸 a partir de la presentaci贸n ante la SEC de Solventum del 8 de agosto de 2025 que informa las acciones en circulaci贸n al 31 de julio de 2025.
3M Company電� Solventum Corporation鞚� 氤错喌欤� 25,569,190欤茧ゼ 氤挫湢頃橁碃 鞛堧嫟瓿� 氤搓碃頄堨溂氅�, 鞚措姅 2025雲� 7鞗� 31鞚� 旮办 氚滍枆欤检嫕 齑濎垬 173,387,798欤茧ゼ 旮办鞙茧 鞎� 14.75%鞐� 頃措嫻頃╇媹雼�. 鞝滌稖靹滊鞐愲姅 3M鞚� 2024雲� 3鞗� 31鞚检瀽 Stockholder and Registration Rights Agreement鞐� 霐半澕 Solventum鞐� 鞙勳瀯鞛レ潉 攵�鞐枅旮� 霑岆鞐� 3M鞚� 頃措嫻 欤检嫕鞐� 雽�頃� 鞚橁舶甓岇潉 頄夓偓頃橃 鞎婌溂氅� 霐半澕靹� 0响�毳� 氤搓碃頃橁碃, 欤检嫕鞚� 毵る弰頃橁卑雮� 觳橂秳 歆�鞁滍暊 靾� 鞛堧姅 雼弲 觳橂秳甓�鞚� 鞙犾頃滊嫟瓿� 氇呾嫓霅橃柎 鞛堨姷雼堧嫟.
Schedule 13G/A電� Kevin H. Rhodes(Executive Vice President, Chief Legal Affairs Officer & Secretary)臧� 2025雲� 8鞗� 18鞚� 3M Company毳� 雽�鞁犿暣 靹滊獏頄堨姷雼堧嫟. 牍勳湪鞚� 2025雲� 7鞗� 31鞚� 旮办 氚滍枆欤检嫕鞚� 氤搓碃頃� Solventum鞚� 2025雲� 8鞗� 8鞚检瀽 SEC 鞝滌稖靹滊ゼ 旮办鞙茧 瓿勳偘霅橃棃鞀惦媹雼�.
3M Company a d茅clar茅 d茅tenir 25 569 190 actions ordinaires de Solventum Corporation, repr茅sentant environ 14,75 % des actions en circulation, sur la base de 173 387 798 actions en circulation au 31 juillet 2025. Le d茅p么t pr茅cise que 3M a accord茅 脿 Solventum une procuration en vertu d'un Stockholder and Registration Rights Agreement en date du 31 mars 2024 ; par cons茅quent, 3M n'exerce pas le pouvoir de vote sur ces actions et d茅clare 0 voix, tout en conservant le pouvoir exclusif de disposition pour vendre ou disposer des actions.
Le Schedule 13G/A a 茅t茅 sign茅 au nom de 3M Company par Kevin H. Rhodes, Executive Vice President, Chief Legal Affairs Officer & Secretary, en date du 18 ao没t 2025. Le pourcentage est calcul茅 脿 partir du d茅p么t aupr猫s de la SEC par Solventum du 8 ao没t 2025, qui rapporte les actions en circulation au 31 juillet 2025.
Die 3M Company meldete den Besitz von 25.569.190 Stammaktien der Solventum Corporation, was etwa 14,75% der ausstehenden Aktien entspricht, basierend auf 173.387.798 ausstehenden Aktien zum 31. Juli 2025. In der Einreichung hei脽t es, dass 3M Solventum gem盲脽 einer Stockholder and Registration Rights Agreement vom 31. M盲rz 2024 eine Vollmacht erteilt hat, weshalb 3M 眉ber diese Aktien keine Stimmrechte aus眉bt und daher 0 Stimmen angibt, w盲hrend sie die ausschlie脽liche Verf眉gungsbefugnis zum Verkauf oder zur anderweitigen Verf眉gung 眉ber die Aktien beh盲lt.
Das Schedule 13G/A wurde im Namen der 3M Company von Kevin H. Rhodes, Executive Vice President, Chief Legal Affairs Officer & Secretary, am 18. August 2025 unterzeichnet. Der Prozentsatz wurde auf Grundlage der SEC-Einreichung von Solventum vom 8. August 2025 berechnet, die die ausstehenden Aktien zum 31. Juli 2025 angibt.
FAQ
How many Solventum (SOLV) shares does 3M own?
What percentage of Solventum does 3M own?
Does 3M have voting control over its Solventum shares?
Can 3M sell the Solventum shares it owns?
When was this Schedule 13G/A signed?
